Showing results (251-260 of 370) with videos related to

Sort By:
Pageof 37
British Journal of Haematology|November 1, 1992
Prevalence of thrombocytopenia in HIV-infected and non-HIV infected drug users and homosexual menG H Mientjes, E J van Ameijden, J W Mulder, et al.
AIDS (London, England)|December 1, 1994
Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactionsD M Burger, P L Meenhorst, C H ten Napel, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|May 3, 2013
Conduction recovery in patients with recurrent atrial fibrillation after pulmonary vein isolation using multi-electrode duty cycled radiofrequency ablationJ C Balt, S Karadavut, A A W Mulder, et al.
Journal of the American Chemical Society|August 14, 2020
Defining Intermediates of Nitrogenase MoFe Protein during N2 Reduction under Photochemical Electron Delivery from CdS Quantum DotsBryant Chica, Jesse Ruzicka, Hayden Kallas, et al.
The Journal of Biological Chemistry|May 16, 2020
The structure and reactivity of the HoxEFU complex from the cyanobacterium Synechocystis sp. PCC 6803Jacob H Artz, Monika Tokmina-Lukaszewska, David W Mulder, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|November 27, 2012
A transoesophageal echocardiographic image acquisition protocol for wide-view fusion of three-dimensional datasets to support atrial fibrillation catheter ablationBen Ren, Harriët W Mulder, Alexander Haak, et al.
Structure (London, England : 1993)|August 11, 2011
Insights into [FeFe]-hydrogenase structure, mechanism, and maturationDavid W Mulder, Eric M Shepard, Jonathan E Meuser, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 24, 2009
Identification and profiling of circulating metabolites of atazanavir, a HIV protease inhibitorR ter Heine, M J X Hillebrand, H Rosing, et al.
Lancet (London, England)|September 8, 1990
Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapyC A Boucher, M Tersmette, J M Lange, et al.
Pageof 37